St Andrews Hospital
- Address
- Kalavriton 37, 26332 Pátrai, Greece
St Andrews Hospital - Geriatric Oncology Research Center
St Andrews Hospital is advancing precision medicine in geriatric oncology through innovative clinical research focused on optimizing cancer treatment for older patients. The center specializes in implementing comprehensive geriatric assessments to personalize therapeutic approaches, ensuring that treatment strategies are tailored to the unique needs and vulnerabilities of elderly cancer populations.
- Dose optimization strategies for CDK 4/6-inhibitors in older breast cancer patients
- Advanced breast cancer management in geriatric populations
- Integration of geriatric assessment tools in oncology treatment decisions
The research program at St Andrews Hospital emphasizes pragmatic, patient-centered trial designs that address real-world challenges in treating vulnerable and frail older patients with advanced malignancies. By investigating time to treatment failure outcomes with modified dosing regimens, the center aims to improve both efficacy and tolerability of modern targeted therapies, including CDK 4/6-inhibitors combined with endocrine therapy, ultimately enhancing quality of life and treatment outcomes for elderly breast cancer patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Region Oerebro Laen1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 173 other sites in Greece
Therapeutic Area Benchmark — Greece
Select a therapeutic area to compare against other sites in Greece.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Greece
Market Share
Country: Greece
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in St Andrews Hospital
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Geriatric Assessment-Guided Dose Optimization of CDK 4/6 Inhibitors in Vulnerable Elderly Patients with Advanced Breast Cancer | Region Oerebro Laen | Phase I | Recruiting | Jan 2024 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Abemaciclib | 1 | Unknown | 2024-01-25 | 2024-01-25 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.